While the mechanism seems to vary between tissues, the connection between increased Ras/MAPK activity and MDSC recruitment appears to be conserved, because our data suggest that MEK activation downstream of oncogenic KRAS drives MDSC recruitment to breast tumors. This evidence concerns the gene MAP2K7 and breast neoplasm.